|
Market Closed -
Hong Kong S.E.
04:08:03 2026-09-04 am EDT
|
5-day change | 1st Jan Change | ||
| 10.09 HKD | -2.32% |
|
-0.10% | -11.41% |
| Aug. 31 | Ascletis Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Aug. 31 | Ascletis Pharma Starts Phase III Trial of Weight-Loss Drug; Shares Plummet 5% | MT |
| Market Cap | 9.13B 10.66B 1.36B 1.17B 1.1B 1.01B 1.88B 128B 1.89B 13B 5.05B 65.85B 5.1B 4.99B 212B | P/E 2026 * |
-13.7x | P/E 2027 * | -10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 7.23B 8.45B 1.08B 927M 872M 797M 1.49B 102B 1.49B 10.31B 4B 52.18B 4.05B 3.96B 168B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 124x |
| Free-Float |
34.01% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 1672 | Delayed | |
OTC Markets
| ASCLF | Delayed | |
|
Deutsche Boerse AG
| 2VJ | Delayed | |
|
Tradegate
| 2VJ | Real-time | |
|
Börse Stuttgart
| 2VJ | Delayed | |
|
Boerse Muenchen
| 2VJ | Real-time |
| 1 day | -2.32% | ||
| 1 week | -0.10% | ||
| Current month | +0.70% | ||
| 1 month | +6.83% | ||
| 3 months | -1.18% | ||
| 6 months | -28.94% | ||
| Current year | -11.41% |
| 1 week | 9.5 |  | 10.64 |
| 1 month | 9.5 | | 11.75 |
| Current year | 7.95 | | 19.86 |
| 1 year | 7.95 | | 19.86 |
| 3 years | 0.76 | | 19.86 |
| 5 years | 0.76 | | 19.86 |
| 10 years | 0.76 | | 19.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinzi Wu
CEO | Chief Executive Officer | 63 | 2013-04-25 |
Yan Yuemei
CTO | Chief Tech/Sci/R&D Officer | - | - |
Handan He
CTO | Chief Tech/Sci/R&D Officer | - | 2019-10-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinzi Wu
CHM | Chairman | 63 | 2018-03-29 |
Jiong Gu
BRD | Director/Board Member | 53 | 2018-03-31 |
| Director/Board Member | 52 | 2019-03-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/26 | Other | Chief Executive Officer | -1,300,000 | 0.1217% | ||
| 7/21/26 | Other | Chief Operating Officer | -1,300,000 | 0.1217% | ||
| 2/10/26 | Other | Chief Operating Officer | 1,300,000 | 0.1301% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.32% | -0.10% | -19.86% | +358.64% | 1.36B | |
| -1.87% | +4.22% | +45.93% | -0.47% | 82.65B | |
| -0.57% | +1.27% | -17.24% | -34.99% | 60.24B | |
| -2.23% | +5.48% | +499.46% | +29.31% | 58.11B | |
| -2.03% | -2.62% | -7.46% | +27.87% | 49.68B | |
| -4.58% | -2.73% | +2.93% | +157.71% | 46.66B | |
| -1.64% | +1.07% | +57.80% | -17.34% | 32.63B | |
| -0.98% | +1.91% | +48.35% | +95.93% | 25.69B | |
| -0.19% | -4.74% | +2.30% | +196.81% | 22.73B | |
| -1.13% | -2.45% | +65.99% | +110.75% | 16.51B | |
| Average | -1.63% | -0.23% | +67.82% | +92.42% | 39.63B | |
| Weighted average by Cap. | -1.68% | +0.74% | +90.32% | +42.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 69.01M 80.61M 10.28M 8.85M 8.32M 7.6M 14.22M 971M 14.26M 98.35M 38.16M 498M 38.6M 37.76M 1.6B |
| Net income | -654M -764M -97.42M -83.83M -78.87M -72.05M -135M -9.2B -135M -932M -362M -4.72B -366M -358M -15.2B | -822M -960M -122M -105M -99.13M -90.56M -169M -11.56B -170M -1.17B -455M -5.93B -460M -450M -19.11B |
| Net Debt | -1.89B -2.21B -282M -243M -228M -209M -390M -26.63B -391M -2.7B -1.05B -13.66B -1.06B -1.04B -44.02B | -577M -673M -85.88M -73.9M -69.53M -63.52M -119M -8.11B -119M -822M -319M -4.16B -322M -315M -13.4B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | HK$10.09 | -2.32% | 1,839,964 |
| 26-09-03 | HK$10.33 | +3.30% | 1,960,610 |
| 26-09-02 | HK$10.00 | +4.82% | 3,564,028 |
| 26-09-01 | HK$9.540 | -4.79% | 1,005,000 |
| 26-08-31 | HK$10.02 | -0.79% | 2,079,120 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1672 Stock
Select your edition
All financial news and data tailored to specific country editions
